Get the Stockscreener App
1.53
1.29%
-0.02
Adagio Medical Holdings Inc stock is traded at $1.53, with a volume of 34,113.
It is down -1.29% in the last 24 hours and up +35.40% over the past month.
Adagio Medical Holdings Inc is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias with its proprietary, catheter-based Ultra-Low Temperature Ablation (ULTA) technology. UTLA is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The company is currently focused on the treatment of ventricular tachycardia (VT), a rapid, abnormal heart rhythm, or arrhythmia, that originates in the heart's lower chambers, or ventricles. The company has one reportable segment.
See More
Previous Close:
$1.55
Open:
$1.5
24h Volume:
34,113
Relative Volume:
0.36
Market Cap:
$33.98M
Revenue:
$137.00K
Net Income/Loss:
$-25.08M
P/E Ratio:
-0.9146
EPS:
-1.6729
Net Cash Flow:
$-19.39M
1W Performance:
+15.04%
1M Performance:
+35.40%
6M Performance:
+5.52%
1Y Performance:
-14.04%
1-Day Range:
$1.4658
$1.56
1-Week Range:
$1.42
$1.69
52-Week Range:
$0.74
$2.582
Adagio Medical Holdings Inc Stock (ADGM) Company Profile
Name
Adagio Medical Holdings Inc
Sector
Industry
Phone
(949) 348-1188
Address
26051 MERIT CIRCLE, LAGUNA HILLS
Compare ADGM vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADGM
Adagio Medical Holdings Inc
|
1.53 | 34.43M | 137.00K | -25.08M | -19.39M | -1.6729 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Adagio Medical Holdings Inc Stock (ADGM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-14-26 | Initiated | Piper Sandler | Overweight |
| Dec-02-25 | Initiated | Lake Street | Buy |
Adagio Medical Holdings Inc Stock (ADGM) Latest News
Adagio Medical Holdings schedules annual meeting for June 16, sets proposal deadlines - Investing.com
Adagio Medical Sets 2026 Annual Meeting, Proposal Deadlines - TipRanks
Adagio Medical (NASDAQ: ADGM) sets 2026 meeting date and April 30 proposal deadline - Stock Titan
Chicago heart meeting gives Adagio's ablation tech a late-breaker stage - Stock Titan
This Cloudflare Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday - Benzinga
ADGM Initiates Coverage On Piper Sandler -- Rating Set to Overwe - GuruFocus
12 Health Care Stocks Moving In Tuesday's Intraday SessionAdagio Medical Holdings (NASDAQ:ADGM), Allog - Benzinga
This Monday.Com Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Tuesday - Benzinga
This SanDisk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
Piper Sandler initiates Adagio Medical stock with overweight rating - Investing.com
Aug Highlights: What is Adagio Medical Holdings Incs valuation compared to sector2026 Biggest Moves & High Return Trade Opportunity Guides - baoquankhu1.vn
Adagio Medical secures FDA clearance to broaden ventricular ablation study - MSN
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Adagio Medical Receives FDA Approval for Next-Gen Ablation System - National Today
FDA expands trial of Adagio’s ventricular tachycardia ablation system - Medical Economics
Adagio Medical Expands IDE Trial for Next-Generation vCLAS System - TipRanks
Adagio Medical receives FDA approval to expand VT ablation trial By Investing.com - Investing.com South Africa
Adagio Medical Receives IDE Approval from the FDA to Investigate Next-Generation vCLAS® Ventricular Ablation System - Weekly Voice
Adagio Medical receives FDA approval to expand VT ablation trial - Investing.com
FDA IDE clears Adagio Medical (NASDAQ: ADGM) vCLAS VT study - Stock Titan
Adagio gets FDA OK to test heart-rhythm catheter aimed at faster procedures - Stock Titan
Adagio Medical to Participate in Annual Needham Conference - National Today
Adagio Medical to Participate in the 25th Annual Needham Virtual Conference - marketscreener.com
[EFFECT] Adagio Medical Holdings, Inc. SEC Filing - Stock Titan
Heart rhythm technology company Adagio joins Needham virtual conference - Stock Titan
ADGM Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Contrasting Adagio Medical (NASDAQ:ADGM) & Waters (NYSE:WAT) - Defense World
Adagio Medical (ADGM) files amendment to replace unsigned auditor consent - Stock Titan
Accounting consent corrected as Adagio Medical (ADGM) files Post-Effective Amendment No. 2 - Stock Titan
Analysts Offer Insights on Healthcare Companies: Centessa Pharmaceuticals (CNTA), UnitedHealth (UNH) and Adagio Medical Holdings (ADGM) - The Globe and Mail
Ultra-low temperature heart-rhythm study gets late-breaking slot - Stock Titan
Adagio Medical (NASDAQ: ADGM) registers 67.96M shares; $96.9M potential warrant proceeds - Stock Titan
Latest ADGM NewsAdagio Medical Reports Third Quarter 2024 R... - Stock Titan
Senti Biosciences, Inc. (SNTI) Reports Q4 Earnings - AlphaStreet
Adagio Medical Holdings, Inc. (ADGM) Reports Q4 Earnings - AlphaStreet
Adagio Medical Holdings, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
ADGM SEC FilingsAdagio Medical 10-K, 10-Q, 8-K Forms - Stock Titan
Adagio Medical (ADGM) registers 67.96M shares for resale; PIPE and convertible components - stocktitan.net
Adagio Medical Holdings 10-K: Revenue $0.0M, EPS $(1.51) - TradingView
Adagio Medical (NASDAQ: ADGM) pairs VT device progress with going concern risk - stocktitan.net
Adagio Medical (NASDAQ: ADGM) cuts 2025 net loss as trial enrollment ends - Stock Titan
Adagio Medical Reports Fourth Quarter and Full Year 2025 Results - ChartMill
Adagio says pivotal VT trial hit 97% acute effectiveness - Stock Titan
Growth Recap: Can Adagio Medical Holdings Inc continue delivering strong returns2026 Trends & Verified Short-Term Trading Plans - baoquankhu1.vn
Adagio Medical Holdings, Inc. (NASDAQ:ADGM) Short Interest Down 79.6% in March - Defense World
Adagio Medical (NASDAQ:ADGM) Trading Up 11.5% – Time to Buy? - Defense World
Adagio Medical Holdings Inc expected to post a loss of 31 cents a shareEarnings Preview - TradingView
Adagio Medical publishes pre-clinical results for next-generation ventricular ablation catheter - Medical Economics
Preclinical heart catheter study points to 30 minutes less procedure time - Stock Titan
If You Invested $1,000 in Adagio Medical (ADGM) - Stock Titan
Adagio Medical Holdings, Inc.: Fundamental Analysis and Financial Ratings | ADGM | US00534B1008 - marketscreener.com
Adagio Medical Holdings Inc Stock (ADGM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.74%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):